Heart Transplant clinical trials at UCSD
4 in progress, 1 open to eligible people
Allograft Dysfunction in Heart Transplant
open to eligible people ages 18 years and up
The investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular and macroscopic causes.
La Jolla, California
Tocilizumab in Cardiac Transplantation
Sorry, not currently recruiting here
The purpose of this research study is to see if a study drug called Tocilizumab will, when given with standard anti-rejection medicines, lead to better heart transplantation outcomes at 1 year after the transplant. Specifically, the investigators will evaluate whether taking tocilizumab leads to less rejection, less development of unwanted antibodies, and better heart function.
La Jolla, California and other locations
Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation
Sorry, in progress, not accepting new patients
This is a prospective, multicenter observational, unblinded, longitudinal cohort study. Subjects will be enrolled into the study prior to or at the time of heart transplantation. All subjects will follow the center's standard of care surveillance schedule. Blood samples will be collected for Prospera testing at the time any surveillance or for-cause testing, which may include endomyocardial biopsy (EMB), echocardiography or other cardiac imaging studies, and/or molecular testing, is performed.
San Diego, California and other locations
Surveillance HeartCare® Outcomes Registry
Sorry, in progress, not accepting new patients
This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.
La Jolla, California and other locations
Our lead scientists for Heart Transplant research studies include Paul Kim, MD Eric D. Adler, MD.
Last updated: